NeoRespiration is a multidisciplinary, peer-reviewed Open Access journal dedicated to addressing global respiratory health challenges driven by climate change, evolving pathogen ecology, population aging, and antimicrobial resistance. It serves as a high-quality international platform that integrates respiratory medicine with biomedical engineering, microbiology, immunology, biomedical materials, medical imaging, artificial intelligence, public health, and preventive medicine. The journal disseminates cutting-edge advances across basic research, technological innovation, and clinical translation, with special emphasis on emerging respiratory infections, invasive fungal diseases, and drug-resistant pathogens, thereby promoting cross-disciplinary collaboration and the translation of scientific findings into clinical solutions and public health strategies.

Topics include, but are not limited to:

1. Emerging and re-emerging respiratory infectious diseases;

2. Invasive fungal diseases and antimicrobial-resistant infections affecting the respiratory system;

3. Biology of respiratory infections and host–pathogen interactions;

4. Pathogenesis and immune regulation of respiratory diseases;

5. Innovative diagnostic technologies and advanced medical imaging for respiratory diseases;

6. Precision medicine and personalized management of respiratory diseases;

7. Artificial intelligence–enabled diagnosis and management of respiratory diseases;

8. Engineering-based therapeutic strategies and biomedical materials for respiratory diseases;

9. Monitoring, critical care, and organ support for patients with severe respiratory disease;

10. Public health prevention, emergency preparedness and response, and health policy for respiratory diseases.

Editorial Board